Homozygous c.14576G&gt;A variant of <i>RNF213</i> predicts early-onset and severe form of moyamoya disease

Satoko Miyatake, Noriko Miyake, Hajime Touho, A. Nishimura-Tadaki, Yasuhiko Kondo, Ichiro Okada, Yoshinori Tsurusaki, Hiroshi Doi, H. Sakai, Hirotomo Saitsu,

Neurology · 2012 · 300 citations · 21 references

Abstract

The homozygous c.14576G>A variant in RNF213 could be a good DNA biomarker for predicting the severe type of MMD, for which early medical/surgical intervention is recommended, and may provide a better monitoring and prevention strategy.

References

21